CNA's Flat P&C Reserves Hide a $77 Million Legacy Mass-Tort Charge

CNA Financial's headline said no net prior-period development in the second quarter of 2026. Its Corporate & Other segment carried a $77 million after-tax charge for unfavorable development on legacy mass-tort and abuse claims, the second consecutive year at that scale (CNA Financial, August 3, 2026).

Both statements are accurate. The segment holding the charge sits entirely outside the P&C combined ratio, and the active book underneath it has an adequacy question of its own.

Key Takeaways

• $77 million after-tax charge on legacy mass-tort and abuse claims, the second consecutive year at that scale, against $88 million in the same quarter of 2025.
• The charge sits in Corporate & Other, a segment holding run-off business that never touches the P&C combined ratio. That is how "no net prior-period development" and a charge this size appear in one release.
• Underlying loss ratio rose 2.6 points to 64.1% against a blended rate change CNA described as flat, with renewal premium change of 2%.
• $106 million of pretax unfavorable development in the first quarter added 4.1 points to the combined ratio, concentrated in excess casualty and professional errors and omissions. Q1 hit the active book, Q2 the legacy one.
• Record $718 million of new business, up 11%, and net written premium up 4%, written into a book whose own loss ratio just moved against it.

Where the $77 Million Actually Sits

Corporate & Other is not a rounding bucket. CNA defines it as corporate debt interest plus "the results of certain property and casualty business in run-off, including asbestos and environmental pollution (A&EP), a legacy portfolio of excess workers' compensation (EWC) policies and legacy mass tort reserves." It holds liabilities from books CNA no longer underwrites. Those are separated from the Commercial, Specialty and International segments that roll into the P&C combined ratio.

The segment posted a core loss of $92 million for the quarter, improved from $114 million a year earlier. That loss contains the $77 million mass-tort charge, described as largely legacy abuse claim activity and the ongoing effects of social inflation, plus $13 million of after-tax amortization tied to CNA's A&EP Loss Portfolio Transfer. The comparable charge a year earlier was $88 million.

That amortization traces to a specific 2010 transaction. CNA ceded approximately $1.6 billion of net asbestos and environmental pollution liabilities to National Indemnity Company under a retroactive loss portfolio transfer with a $4 billion aggregate limit. It paid a $2 billion premium against a $2.2 billion collateral trust, with a Berkshire guarantee behind it (Insurance Journal, July 2010).

Sixteen years on, the deferred gain is still amortizing through the same quarterly line as an active abuse-claim problem that has nothing to do with asbestos. The A&EP liabilities are reinsured to the $4 billion limit, so that $13 million is a bookkeeping artifact. The mass-tort and legacy EWC pieces beside it are not: those are current strengthening on claims CNA still carries net.

The Active Book's Own Signal

Set the Corporate charge aside and the P&C book still moved. The all-in combined ratio came in at 96.5% against 94.1%, with catastrophe losses of $60 million contributing 2.3 points, essentially flat to the $62 million and 2.4 points a year earlier. Strip catastrophes and the underlying combined ratio was 94.2%, up 2.5 points, while the underlying loss ratio rose to 64.1% from 61.5%. The expense ratio held at 29.7%.

What makes that 2.6-point drift a pricing signal rather than noise is the rate sitting next to it. CNA's overall rate change was flat, with renewal premium change of 2% blended across a book where Specialty and casualty pushed rate up while property, workers' compensation and International moved down. A loss ratio rising 2.6 points against roughly no rate movement is either a loss-trend assumption that understated severity when the 2026 accident-year picks were set, a genuine deterioration emerging faster than expected, or both.

Growth is not pausing while that resolves. Net written premium rose 4%, new business hit a record $718 million, up 11%, and retention held at 83%. CNA is writing more premium into a book whose loss ratio just moved against it, which raises rather than lowers the stakes on the 2026 picks.

The first quarter already flagged the active side. CNA booked $106 million of pretax unfavorable development, adding 4.1 points and pushing the combined ratio to 102.2% from 98.4%. Of that, $56 million sat in Commercial excess casualty and $50 million in Specialty professional errors and omissions (actuary.info, Q1 2026). Management tied it to recent accident years, meaning the 2022 through 2024 hard-market vintages deteriorating before their fourth or fifth development year.

Peers split the same way. Everest booked roughly $200 million of North America casualty strengthening inside its active combined ratio, and Hartford funded a casualty build with short-tail releases. Marsh's index put US casualty rates excluding workers' compensation up 11% against a global composite down 6% (Marsh, July 2026).

What Segment Placement Does to Scrutiny

CNA is not unusual in carrying legacy mass-tort and A&EP exposure in a run-off segment. The practice is common among large-cap carriers with older liability tails and it exists for defensible reasons, including that run-off is managed by a different team on a different reserving cadence than active underwriting.

The consequence is still that a real charge on genuine claims exposure does not reach the metric most readers use as a reserve-adequacy proxy. Everest's strengthening printed inside its combined ratio. Its CFO told analysts the company "decided to react now to what we're seeing in the data and not wait till the reserve studies are done next quarter" (Elias Habayeb, Everest Group Q2 2026 earnings call, July 30, 2026). CNA's charge is equally real and sits where the combined ratio does not look.

That shapes what gets pressed on. Analysts and rating agencies anchoring reserve questions to the P&C combined ratio have less occasion to work through Corporate-segment detail that does not move the number they model. A charge recurring for a second consecutive year outside the headline metric can compound with less external pressure behind resolving it.

The backdrop says the exposure is structural rather than a one-off overrun. The US P&C industry posted $15.8 billion of adverse prior-year casualty development in 2024, a record for those segments. Swiss Re's Social Inflation Index peaked at 7% in 2023, and nuclear verdicts above $10 million rose 52% in 2024 to a record 135 cases. Sexual abuse and molestation litigation on revived statutes of limitation is one of the named drivers, industry-wide rather than CNA-specific. A third consecutive Corporate-segment charge in 2027 would read as an unresolved legacy liability rather than a cost overrun.